ABSTRACT
Reperfusion therapy has contributed to decreased morbidity and mortality in patients with acute myocardial infarction (AMI). Implementation of thrombolytic therapy, primary angioplasty and emergency coronary artery by-pass surgery have proved to be effective in well designed controlled clinical trials. There is little information, however about the impact of reperfusion therapy in the general clinical population that is usually seen in the coronary care unit. In this paper we have compared the clinical course, morbidity and mortality of patients attended for a first AMI in 2 different periods. Multivariate analysis showed that age and heart failure were significant independent predictors of mortality in both periods. Thus, there has been a significant change in the therapeutic approach to AMI patients in recent years. Widespread utilization of reperfusion therapy appears to be associated with decrease in morbidity and mortality in a general population of patients with a first AMI
Subject(s)
Humans , Male , Female , Adult , Middle Aged , Myocardial Infarction/therapy , Myocardial Reperfusion/methods , Smoking/adverse effects , Risk Factors , Age Factors , Hospital Mortality , Myocardial Infarction/mortality , Fibrinolytic Agents/administration & dosage , Hospitalization/statistics & numerical data , Shock, Cardiogenic/epidemiologyABSTRACT
The aim of this work was to measure oxygen consumption and carbon dioxide production during exercise in 21 subjects with cardiac failure and 13 normal subjects. During the resting period, subjects with cardiac failure had higher ventilatory frequency and respiratory quotient than normals. During maximal exercise, the former achieved higher ventilatory frequency and oxygen ventilatory equivalent than normals. In subjects with cardiac failure and normals, anerobic thresholds were 14,4ñ0,9 and 28,8ñ2,2 ml/kg/min respectively and peak oxygen consumptions 17,1ñ1 and 34,4ñ1,7 ml/kg/min respectively. There were less than 10 percent differences in parameters when tests were repeated in 10 subjects with cardiac failure. It is concluded that gas exchange testing may be a reliable and objective assessment method in patients with cardiac failure